Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;117(2):317-23.
doi: 10.1016/j.ygyno.2010.01.022. Epub 2010 Feb 16.

A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors

Jeanne Carter  1 , Leigh Raviv, Kathleen Appollo, Raymond E Baser, Alexia Iasonos, Richard R Barakat
Affiliations

A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors

Jeanne Carter et al. Gynecol Oncol. 2010 May.

Abstract

Objective: This study aimed to determine the feasibility and efficacy of using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a symptom scale for lymphedema of the lower extremity (LLE).

Methods: Twenty-eight gynecologic cancer survivors with documented LLE and 30 without a history or presence of lymphedema completed the GCLQ and provided feedback about their satisfaction with and feasibility of using the GCLQ at their oncology follow-ups. The study survey took approximately 5-10 min to complete, and it was easily understood by the majority of the sample.

Results: Participants had a mean age of 59.6 years (range, 28-80 years). Twenty-eight women (48%) had LLE, and 30 (52%) had no history or presence of LLE (confirmed by limb volume [LV] measurements at assessment). Type of cancer history included endometrial, 38 (66%); cervical, 13 (22%); and vulvar, 7 (12%). GCLQ scores differed significantly by lymphedema diagnosis; LLE patients had higher scores (P<0.01). The large area under the curve (AUC) of 0.95 (95% CI: 0.90-1.000) suggests that the GCLQ can distinguish between patients with and without LLE. Although all 28 (100%) of the LLE patients were aware of their LLE diagnosis, only 23 (82%) underwent treatment. The GCLQ was easily understood by most (55/58, 95%), and overall, patients showed a high willingness (56/58, 96%) to complete the questionnaire at future appointments. Twenty-five (88%) of the LLE patients found the GCLQ to be helpful in identifying symptoms of lymphedema.

Conclusions: The GCLQ effectively distinguished between gynecologic cancer survivors with and those without LLE, with good sensitivity and specificity. The patients, particularly those with LLE, showed high confidence in the GCLQ's ability to detect LLE symptoms.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT

  1. Jeanne Carter, PhD: no conflicts of interest to declare

  2. Leigh Raviv, BA: no conflicts of interest to declare

  3. Kathleen Appollo, RN: no conflicts of interest to declare

  4. Alexia Iasonos, PhD: no conflicts of interest to declare

  5. Raymond E. Baser, MS: no conflicts of interest to declare

  6. Richard R. Barakat, MD: no conflicts of interest to declare

Figures

Figure 1
Figure 1
Receiver Operating Characteristic (ROC) Curve for GCLQ Total Score Compared to Lymphedema Diagnosis Gold-Standard
See this image and copyright information in PMC

References

    1. Lymphoedema Framework. International consensus. London: MEP Ltd; 2006. Best Practice for the Management of Lymphoedema.
    1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology. 2003;36:84–91. - PubMed
    1. Badger C, Preston N, Seers K, Mortimer P. Physical therapies for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev. 2004;(4):CD003141. - PubMed
    1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. 2009 Consensus Document of the International Society of Lymphology. Lymphology. 2009;42:51–60. - PubMed
    1. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–77. - PubMed